Big Pharma conspiracy
I am writing about CBP’s new rule, “Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry,” which could effectively end many Americans’ ability to personally import prescription medicines after Oct. 22, 2026.
For patients like me, this is not an abstract policy issue. I have stage 4 kidney disease, and access to affordable medication matters. Generic empagliflozin costs about $1.20 per 10 mg tablet in Canada, the EU, and the UK, while the U.S. brand-name version, Jardiance, costs about $8.30 per tablet. When a safe, affordable option exists abroad, patients should not be forced to pay far more at home. Congress should act to preserve access to legitimate, certified pharmacies and protect patients from losing affordable treatment options. To learn more or take action, visit personalimportation.org for resources and a sample letter to Congress.